inclusion criteria: 1. sign the informed consent before initiating the selection procedures. 2. patients infected with sars-cov-2 (pcr +) with mild symptoms up to 7 days that do not require hospitalization, from the onset of symptoms. mild symptoms, defined as the following criteria: cough, headache, fever (\>37.5ºc), muscular pain and shortness of breath. 3. people ≥ 18 years. 4. peripheral oxygen saturation (spo2) more than 94% on room air, not requiring supplemental oxygen. 5. availability to meet the requirements of the protocol.

inclusion criteria: 1. sign the informed consent before initiating the selection procedures. 2. patients infected with sars-cov-2 (pcr +) with mild symptoms up to 7 days that do not require hospitalization, from the onset of symptoms. mild symptoms, defined as the following criteria: cough, headache, fever (\>37.5ºc), muscular pain and shortness of breath. 3. people ≥ 18 years. 4. peripheral oxygen saturation (spo2) more than 94% on room air, not requiring supplemental oxygen. 5. availability to meet the requirements of the protocol.

inclusion criteria: sign the informed consent before initiating the selection procedures. patients infected with sars-cov-2 (pcr +) with mild symptoms up to 7 days that do not require hospitalization, from the onset of symptoms. mild symptoms, defined as the following criteria: cough, headache, fever (>37.5ºc), muscular pain and shortness of breath. people ≥ 18 years. peripheral oxygen saturation (spo2) more than 94% on room air, not requiring supplemental oxygen. availability to meet the requirements of the protocol.

inclusion criteria: sign the informed consent before initiating the selection procedures. patients infected with sars-cov-2 (pcr +) with mild symptoms up to 7 days that do not require hospitalization, from the onset of symptoms. mild symptoms, defined as the following criteria: cough, headache, fever (>37.5ºc), muscular pain and shortness of breath. people ≥ 18 years. peripheral oxygen saturation (spo2) more than 94% on room air, not requiring supplemental oxygen. availability to meet the requirements of the protocol.

inclusion criteria: 1. sign the informed consent before initiating the selection procedures. 2. patients infected with sars-cov-2 (pcr +) with mild symptoms up to 7 days that do not require hospitalization, from the onset of symptoms. mild symptoms, defined as the following criteria: cough, headache, fever (>37.5ºc), muscular pain and shortness of breath. 3. people ≥ 18 years. 4. peripheral oxygen saturation (spo2) more than 94% on room air, not requiring supplemental oxygen. 5. availability to meet the requirements of the protocol.

inclusion criteria: 1. sign the informed consent before initiating the selection procedures. 2. patients infected with sars-cov-2 (pcr +) with mild symptoms up to 7 days that do not require hospitalization, from the onset of symptoms. mild symptoms, defined as the following criteria: cough, headache, fever (>37.5ºc), muscular pain and shortness of breath. 3. people ≥ 18 years. 4. peripheral oxygen saturation (spo2) more than 94% on room air, not requiring supplemental oxygen. 5. availability to meet the requirements of the protocol.